Ultrasound in Clinically Suspect Arthralgia: the Role of Power Doppler to Predict Rheumatoid Arthritis Development

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2021 Dec 8

PMID 34876221

Citations 6

Authors

Juan Molina Collada

Katerine Lopez Gloria

Isabel Castrejon

Juan Carlos Nieto-Gonzalez

Javier Rivera

Fernando Montero

Carlos Gonzalez

Jose Maria Alvaro-Gracia

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the usefulness of power Doppler (PD) ultrasound (US) to predict rheumatoid arthritis (RA) development in patients with clinically suspect arthralgia (CSA).

Methods: Retrospective analysis of a US unit cohort over a 1-year period. Patients with CSA and no previous diagnosis of inflammatory arthritis (IA) were included for analysis. All underwent bilateral US examination of the hands and/or feet according to the EULAR guidelines. Active US inflammation was defined as PD synovitis and/or tenosynovitis ≥1 at any location. RA diagnosis according to clinician criteria 6 months after the US examination was checked. Univariate and multivariate logistic regression models were employed to investigate possible predictive factors of RA development.

Results: A total of 110 CSA patients (80 females, mean age 53.6 years) were included for analysis. After 6 months of follow-up, 14 (12.7%) developed RA and 34 (30.9%) IA. US active inflammation was present in 38 (34.5%) patients (28.2% showed PD synovitis and 18.2% PD tenosynovitis). Multivariate analysis showed that ACPA (OR 1.0003; 95% CI 1.002-1.006) and ESR (OR 1.054; 95% CI 1.016-1.094) were significantly associated with the detection of US active inflammation at baseline. Only PD tenosynovitis was found to be an independent predictive factor of an evolution towards RA (OR 6.982; 95% CI 1.106-44.057) and IA (OR 5.360; 95% CI 1.012-28.390).

Conclusion: US is able to detect features of subclinical inflammation in CSA patients, especially in those with higher ESR and ACPA values. Only PD tenosynovitis at baseline US assessment was found to be an independent predictor of RA and IA development in CSA patients.

Citing Articles

The So-Called Pre-Clinical Rheumatoid Arthritis: Doubts, Challenges, and Opportunities.

Sanmarti R, Frade-Sosa B, Ponce A J Clin Med. 2024; 13(21).

PMID: 39518527 PMC: 11546573. DOI: 10.3390/jcm13216387.

Practical Use of Ultrasound in Modern Rheumatology-From A to Z.

Sapundzhieva T, Sapundzhiev L, Batalov A Life (Basel). 2024; 14(9).

PMID: 39337990 PMC: 11433054. DOI: 10.3390/life14091208.

Biomarkers in the diagnosis, prognosis and management of rheumatoid arthritis: A comprehensive review.

Sahin D, Di Matteo A, Emery P Ann Clin Biochem. 2024; 62(1):3-21.

PMID: 39242085 PMC: 11707974. DOI: 10.1177/00045632241285843.

Patient-reported swelling in arthralgia patients at risk for rheumatoid arthritis: is it of value?.

Boeren A, Khidir S, de Jong P, van der Helm-van Mil A, van Mulligen E Rheumatology (Oxford). 2023; 63(12):3415-3421.

PMID: 37952171 PMC: 7616518. DOI: 10.1093/rheumatology/kead606.

Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction.

Di Matteo A, De Lorenzis E, Duquenne L, Nam J, Garcia-Montoya L, Harnden K Rheumatology (Oxford). 2023; 63(8):2213-2221.

PMID: 37934127 PMC: 11292136. DOI: 10.1093/rheumatology/kead570.

References

Torp-Pedersen S, Terslev L . Settings and artefacts relevant in colour/power Doppler ultrasound in rheumatology. Ann Rheum Dis. 2007; 67(2):143-9. DOI: 10.1136/ard.2007.078451. View

Rakieh C, Nam J, Hunt L, Hensor E, Das S, Bissell L . Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann Rheum Dis. 2014; 74(9):1659-66. DOI: 10.1136/annrheumdis-2014-205227. View

Saraux A, Berthelot J, Chales G, Le Henaff C, Thorel J, Hoang S . Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum. 2001; 44(11):2485-91. DOI: 10.1002/1529-0131(200111)44:11<2485::aid-art428>3.0.co;2-s. View

Filer A, de Pablo P, Allen G, Nightingale P, Jordan A, Jobanputra P . Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann Rheum Dis. 2010; 70(3):500-7. PMC: 3033529. DOI: 10.1136/ard.2010.131573. View

Caporali R, Smolen J . Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis management. Ann Rheum Dis. 2017; 77(1):18-20. DOI: 10.1136/annrheumdis-2017-211458. View

Wakefield R, Gibbon W, Conaghan P, OConnor P, McGonagle D, Pease C . The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum. 2001; 43(12):2762-70. DOI: 10.1002/1529-0131(200012)43:12<2762::AID-ANR16>3.0.CO;2-#. View

Nell V, Machold K, Eberl G, Stamm T, Uffmann M, Smolen J . Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2004; 43(7):906-14. DOI: 10.1093/rheumatology/keh199. View

van den Berg R, Ohrndorf S, Kortekaas M, van der Helm-van Mil A . What is the value of musculoskeletal ultrasound in patients presenting with arthralgia to predict inflammatory arthritis development? A systematic literature review. Arthritis Res Ther. 2018; 20(1):228. PMC: 6235211. DOI: 10.1186/s13075-018-1715-8. View

van Beers-Tas M, Blanken A, Nielen M, Turkstra F, van der Laken C, Meursinge Reynders M . The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study. Arthritis Res Ther. 2018; 20(1):279. PMC: 6300036. DOI: 10.1186/s13075-018-1767-9. View

10.

DAgostino M, Terslev L, Wakefield R, Ostergaard M, Balint P, Naredo E . Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission. Ann Rheum Dis. 2016; 75(11):1902-1908. DOI: 10.1136/annrheumdis-2016-209646. View

11.

Grassi W, Filippucci E, Farina A, Salaffi F, CERVINI C . Ultrasonography in the evaluation of bone erosions. Ann Rheum Dis. 2001; 60(2):98-103. PMC: 1753465. DOI: 10.1136/ard.60.2.98. View

12.

Duquenne L, Chowdhury R, Mankia K, Emery P . The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on "At-Risk" Individuals. Front Med (Lausanne). 2020; 7:587827. PMC: 7662561. DOI: 10.3389/fmed.2020.587827. View

13.

Rogier C, Wouters F, van Boheemen L, van Schaardenburg D, de Jong P, van der Helm-van Mil A . Subclinical synovitis in arthralgia: how often does it result in clinical arthritis? Reflecting on starting points for disease-modifying anti-rheumatic drug treatment. Rheumatology (Oxford). 2020; 60(8):3872-3878. PMC: 8328495. DOI: 10.1093/rheumatology/keaa774. View

14.

Zufferey P, Rebell C, Benaim C, Ziswiler H, Dumusc A, So A . Ultrasound can be useful to predict an evolution towards rheumatoid arthritis in patients with inflammatory polyarthralgia without anticitrullinated antibodies. Joint Bone Spine. 2016; 84(3):299-303. DOI: 10.1016/j.jbspin.2016.05.011. View

15.

Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, van Venrooij W . A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 2004; 6(4):R303-8. PMC: 464874. DOI: 10.1186/ar1187. View

16.

van de Stadt L, Witte B, Bos W, van Schaardenburg D . A prediction rule for the development of arthritis in seropositive arthralgia patients. Ann Rheum Dis. 2012; 72(12):1920-6. DOI: 10.1136/annrheumdis-2012-202127. View

17.

Colebatch A, Edwards C, Ostergaard M, van der Heijde D, Balint P, DAgostino M . EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013; 72(6):804-14. DOI: 10.1136/annrheumdis-2012-203158. View

18.

Chibnik L, Mandl L, Costenbader K, Schur P, Karlson E . Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis. J Rheumatol. 2009; 36(4):706-11. PMC: 3108039. DOI: 10.3899/jrheum.080895. View

19.

Ruta S, Sanchez Prado E, Chichande J, Ruta A, Salvatori F, Magri S . EULAR definition of "arthralgia suspicious for progression to rheumatoid arthritis" in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound. Clin Rheumatol. 2020; 39(5):1493-1499. DOI: 10.1007/s10067-019-04855-0. View

20.

Goekoop-Ruiterman Y, de Vries-Bouwstra J, Allaart C, van Zeben D, Kerstens P, Hazes J . Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum. 2008; 58(2 Suppl):S126-35. DOI: 10.1002/art.23364. View